Curcumin modulates efflux mediated by yeast ABC multidrug transporters and is synergistic with antifungals

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 8, 2009, Pages 3256-3265

  Sharma, Monika ^a   Manoharlal, Raman ^a   Shukla, Suneet ^b   Puri, Nidhi ^a   Prasad, Tulika ^a   Ambudkar, Suresh V ^b   Prasad, Rajendra ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANISOMYCIN; ANTIFUNGAL AGENT; ASCOMYCIN; CURCUMIN; CYCLOHEXIMIDE; FLUCONAZOLE; GLYCOPROTEIN P; IODINE; IODOARYLAZIDOPRAZOSIN IODINE 25; ITRACONAZOLE; KETOCONAZOLE; METHOTREXATE; MICONAZOLE; MUTANT PROTEIN; PRAZOSIN; PROTEIN ABC; RHODAMINE; UNCLASSIFIED DRUG; VORICONAZOLE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; DRUG SENSITIVITY; DRUG STRUCTURE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; YEAST;

ANISOMYCIN; ANTIFUNGAL AGENTS; BIOLOGICAL TRANSPORT; CANDIDA ALBICANS; CURCUMIN; CYCLOHEXIMIDE; DRUG SYNERGISM; ENZYME INHIBITORS; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; METHOTREXATE; MICONAZOLE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PYRIMIDINES; RHODAMINES; SACCHAROMYCES CEREVISIAE; TRIAZOLES;

EID: 67749099622     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01497-08     Document Type: Article

References (32)

1. Ammon, H. P., and M. A. Wahl. 1991. Pharmacology of Curcuma longa. Planta Med. 57:1-7.
2. Anuchapreeda, S., P. Leechanachai, M. M. Smith, S. V. Ambudkar, and P. N. Limtrakul. 2002. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem. Pharmacol. 64:573-582.
3. Chearwae, W., S. Anuchapreeda, K. Nandigama, S. V. Ambudkar, and P. Limtrakul. 2004. Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from turmeric powder. Biochem. Pharmacol. 68:2043-2052.
4. Chearwae, W., S. Shukla, P. Limtrakul, and S. V. Ambudkar. 2006. Modulation of the function of the multidrug resistance-linked ATP-binding cassette transporter ABCG2 by the cancer chemopreventive agent curcumin. Mol. Cancer Ther. 5:1995-2006.
5. Chearwae, W., C. P. Wu, H. Y. Chu, T. R. Lee, S. V. Ambudkar, and P. Limtrakul. 2006. Curcuminoids purified from turmeric powder modulate the function of human multidrug resistance protein 1 (ABCC1). Cancer Chemother. Pharmacol. 57:376-388.
6. Choi, B. H., C. G. Kim, Y. Lim, S. Y. Shin, and Y. H. Lee. 2008. Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/ Akt/NFKB pathway. Cancer Lett. 259:111-118.
7. Decottignies, A., A. M. Grant, J. W. Nichols, H. De Wet, D. B. McIntosh, and A. Goffeau. 1998. ATPase and multidrug transport activities of the overexpressed yeast ABC protein Yor1p. J. Biol. Chem. 273:12612- 12622.
8. Fonzi, W. A., and M. Y. Irwin. 1993. Isogenic strain construction and gene mapping in Candida albicans. Genetics 134:717-728.
9. Gaur, M., D. Choudhury, and R. Prasad. 2005. Complete inventory of ABC proteins in human pathogenic yeast, Candida albicans. J. Mol. Microbiol. Biotechnol. 9:3-15.
10. Gaur, M., N. Puri, R. Manoharlal, V. Rai, G. Mukhopadhayay, D. Choudhury, and R. Prasad. 2008. MFS transportome of the human pathogenic yeast Candida albicans. BMC Genomics 9:579.
11. Gottesman, M. M., T. Fojo, and S. E. Bates. 2002. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer 2:48-58.
12. Holmes, A. R., Y. H. Lin, K. Niimi, E. Lamping, M. Keniya, M. Niimi, K. Tanabe, B. C. Monk, and R. D. Cannon. 2008. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates. Antimicrob. Agents Chemother. 52: 3851-3862.
13. Hunter, C. A., and J. K. M. Sanders. 1990. The nature of π-π interactions. J. Am. Chem. Soc. 112:5525-5534.
14. Hunter, C. A., J. Singh, and J. M. Thornton. 1991. Pi-pi interactions: the geometry and energetics of phenylalanine-phenylalanine interactions in proteins. J. Mol. Biol. 218:837-846.
15. Krishnamurthy, S., U. Chatterjee, V. Gupta, R. Prasad, P. Das, P. Snehlata, S. E. Hasnain, and R. Prasad. 1998. Deletion of transmembrane domain 12 of CDR1, a multidrug transporter from Candida albicans, leads to altered drug specificity: expression of a yeast multidrug transporter in baculovirus expression system. Yeast 14:535-550.
16. Kuo, M. L., T. S. Huang, and J. K. Lin. 1996. Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim. Biophys. Acta 1317:95-100.
17. Lamping, E., B. C. Monk, K. Niimi, A. R. Holmes, S. Tsao, K. Tanabe, M. Niimi, Y. Uehara, and R. D. Cannon. 2007. Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyces cerevisiae. Eukaryot. Cell 6:1150-1165.
18. Limtrakul, P., W. Chearwae, S. Shukla, C. Phisalphong, and S. V. Ambudkar. 2007. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin. Mol. Cell. Biochem. 296:85-95.
19. Litman, T., T. E. Druley, W. D. Stein, and S. E. Bates. 2001. From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell. Mol. Life Sci. 58:931-959.
20. Nakamura, K., M. Niimi, K. Niimi, A. R. Holmes, J. E. Yates, A. Decottignies, B. C. Monk, A. Goffeau, and R. D. Cannon. 2001. Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters. Antimicrob. Agents Chemother. 45:3366-3374.
21. Niimi, K., D. R. Harding, R. Parshot, A. King, D. J. Lun, A. Decottignies, M. Niimi, S. Lin, R. D. Cannon, A. Goffeau, and B. C. Monk. 2004. Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative. Antimicrob. Agents Chemother. 48:1256-1271.
22. + transport. Eukaryot. Cell 6:443-453.
23. Prasad, R., N. A. Gaur, M. Gaur, and S. S. Komath. 2006. Efflux pumps in drug resistance of Candida. Infect. Disord. Drug Targets 6:69-83.
24. Saini, P., T. Prasad, N. A. Gaur, S. Shukla, S. Jha, S. S. Komath, L. A. Khan, Q. M. Haq, and R. Prasad. 2005. Alanine scanning of transmembrane helix 11 of Cdr1p ABC antifungal efflux pump of Candida albicans: identification of amino acid residues critical for drug efflux. J. Antimicrob. Chemother. 56:77-86.
25. Sanglard, D., and F. C. Odds. 2002. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect. Dis. 2:73-85.
26. Shukla, S., V. Rai, D. Banerjee, and R. Prasad. 2006. Characterization of Cdr1p, a major multidrug efflux protein of Candida albicans: purified protein is amenable to intrinsic fluorescence analysis. Biochemistry 45:2425-2435.
27. Shukla, S., P. Saini, Smriti, S. Jha, S. V. Ambudkar, and R. Prasad. 2003. Functional characterization of Candida albicans ABC transporter Cdr1p. Eukaryot. Cell 2:1361-1375.
28. Shukla, S., H. Zaher, A. Hartz, B. Bauer, J. A. Ware, and S. V. Ambudkar. 2009. Curcumin inhibits the activity of ABCG2/BCRP1, a multidrug resistance-linked ABC drug transporter in mice. Pharm. Res. 26:480-487.
29. Smith, W. L., and T. D. Edlind. 2002. Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation. Antimicrob. Agents Chemother. 46:3532-3539.
30. Tanabe, K., E. Lamping, K. Adachi, Y. Takano, K. Kawabata, Y. Shizuri, M. Niimi, and Y. Uehara. 2007. Inhibition of fungal ABC transporters by unnarmicin A and unnarmicin C, novel cyclic peptides from marine bacterium. Biochem. Biophys. Res. Commun. 364:990-995.
31. Vermitsky, J. P., and T. D. Edlind. 2004. Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor. Antimicrob. Agents Chemother. 48: 3773-3781.
32. White, T. C., K. A. Marr, and R. A. Bowden. 1998. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11:382-402.